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Mitochondria undergo continual cycles of fusion and
fission, and the balance of these opposing processes reg-
ulates mitochondrial morphology. Paradoxically, cells
invest many resources to maintain tubular mitochon-
drial morphology, when reducing both fusion and fis-
sion simultaneously achieves the same end. This obser-
vation suggests a requirement for mitochondrial fusion,
beyond maintenance of organelle morphology. Here, we
show that cells with targeted null mutations in Mfn1 or
Mfn2 retained low levels of mitochondrial fusion and
escaped major cellular dysfunction. Analysis of these
mutant cells showed that both homotypic and hetero-
typic interactions of Mfns are capable of fusion. In con-
trast, cells lacking both Mfn1 and Mfn2 completely
lacked mitochondrial fusion and showed severe cellular
defects, including poor cell growth, widespread hetero-
geneity of mitochondrial membrane potential, and de-
creased cellular respiration. Disruption of OPA1 by
RNAi also blocked all mitochondrial fusion and resulted
in similar cellular defects. These defects in Mfn-null or
OPA1-RNAi mammalian cells were corrected upon res-
toration of mitochondrial fusion, unlike the irreversible
defects found in fzo yeast. In contrast, fragmentation
of mitochondria, without severe loss of fusion, did not
result in such cellular defects. Our results showed that
key cellular functions decline as mitochondrial fusion is
progressively abrogated.
Mitochondrial dynamics involves the two opposing processes
of fusion and fission (1, 2). In cultured cells, an equilibrium is
achieved between the two processes, and thus a relatively
stable but dynamic morphology is maintained. In mouse em-
bryonic fibroblasts (MEFs),1 for example, a tubular network of
mitochondria normally predominates. If fusion is inhibited,
however, unopposed fission leads to mitochondrial fragmenta-
tion (3).
In mammalian cells, the large mitochondrial GTPases Mito-
fusin 1 (Mfn1), Mitofusin 2 (Mfn2), and OPA1 play important
roles in mitochondrial fusion (3–8). In humans, mutations in
Mfn2 cause Charcot-Marie-Tooth neuropathy type 2A (9), and
mutations inOPA1 cause dominant optic atrophy (10, 11). Mice
lacking either of the mitofusins die as embryos, with Mfn2-null
mice showing placental insufficiency (3). To understand these
diverse tissue-specific phenotypes, it will be critical to elucidate
the relative importance of Mfn1, Mfn2, and OPA1 in specific
cell types. In particular, Mfn1 and Mfn2 appear to play similar
roles in mitochondrial fusion, but the degree of redundancy
between these homologs and whether they can cooperate in
mitochondrial fusion remains to be determined.
On a cellular level, the best known function of mitochondrial
fusion is to maintain mitochondrial morphology (12, 13). Given
the highly ordered arrangement of mitochondrial networks in
some cell types (14), it is likely that mitochondrial shape indeed
has important consequences for mitochondrial function. Nev-
ertheless, there are clues that mitochondrial fusion has addi-
tional functions beyond regulation of morphology. First, the
in vivo rates of mitochondrial fusion and fission far exceed
those necessary to maintain tubular mitochondrial morphol-
ogy. Cells with greatly reduced rates can have tubular mito-
chondria, as long as the fusion and fission rates are appropri-
ately balanced (3). Second, in Mfn1-null or Mfn2-null cells, a
small subset of mitochondria lose their membrane potential
() (3). We have hypothesized that mitochondrial dynamics
protects mitochondria by ensuring that stochastic depletion of
materials, such as metabolic substrates or mitochondrial DNA
(mtDNA), is transient. Without fusion, however, these deficien-
cies persist, accumulate, and result in cellular dysfunction.
In this study, we examined the dependence of mitochondrial
fusion on Mfn1, Mfn2, and OPA1 and demonstrated that cells
lacking all mitochondrial fusion show defects in key cellular
functions. Fusion-defective cells have dramatically reduced
growth rates, reduced respiration, and a highly heterogeneous
mitochondrial population prone to loss of .
EXPERIMENTAL PROCEDURES
Cell Lines and Culture—To generate Mfn-dm cells, MEFs were first
derived from Mfn1/, Mfn2-/conditional embryos (carrying one copy
of a loxP-flanked conditional allele ofMfn2), as described previously (3).
Transient transfection with a Cre-enhanced GFP expression plasmid,
followed by cell sorting for Cre-GFP expression, was used to isolate
Mfn-dm cells. The genotypes of all mutant cells were confirmed by PCR
analysis. Mfn-dm and OPA1-RNAi lines were derived and maintained
in rich medium (Dulbecco’s modified Eagle’s medium supplemented
with 15% fetal calf serum, 1 mM pyruvate, 50 g/ml uridine). All other
cell lines were maintained in standard medium (Dulbecco’s modified
Eagle’s medium supplemented with 10% bovine calf serum). All exper-
iments involving retroviral infection were conducted on both freshly
infected bulk cultures and multiple clonal lines.
Mitochondrial  was monitored, as described previously (3), except
that mitochondria were detected by expression Su9-GFP (enhanced
GFP with the mitochondrial presequence of subunit 9 of the F0-
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ATPase). Z-stacks of images acquired on a Zeiss Axiovert 200 M micro-
scope were deconvolved using the iterative algorithm in AxioVision 4.2
and presented as maximum intensity projections.
For cell growth measurements, parental control cultures were split
in two and either mock-infected or infected with the experimental virus.
Cells were then plated onto two 6-well plates, at 6  104 cells/well in
their respective growth media. 4 h later, the cells were counted, in
triplicate, to constitute the day 0 score. At this time, the medium in the
remaining 9 wells of each cell line was changed to standard medium.
The cells were then counted, in triplicate, on days 2, 3, and 4.
Short Hairpin RNA (shRNA) Construction—For RNA interference
(RNAi) studies, we constructed retroviral vectors expressing short hairpin
RNAs from the human H1-RNA promoter. The H1-RNA promoter was
cloned into pBKSII (Stratagene), as described previously (15). The pMN-
D-BANSHEE vector carrying GFP (gift of Drs. G. Hernandez-Hoyos
and J. Ila-Alberola, California Institute of Technology) and pMND-BA-
NSHEE vector carrying Neo(R) (gift of Dr. J. Rossi, City of Hope, CA)
were digested with BglII and StuI. The H1 promoter was then inserted
as a BamHI/HincII fragment to make the retroviral vectors pBG and
pBN, respectively. shRNA constructs were then inserted as annealed
oligonucleotides into BglII/HindIII sites. An RNAi-resistantOPA1 cons-
truct was made by altering codons for residues 13–18 (from gtc tgc caa
tcc tta gtg to gtg tgt cag tcg ttg gta). Retrovirus was prepared from these
plasmids and used to infect MEFs, as described previously (3). The
following oligonucleotides were used: anti-OPA1-f, 5-gatccccgtctgtcaa-
tccttagtgattcaagagatcactaaggattggcagactttttggaaa-3; anti-OPA1-r, 5-
agcttttccaaaaagtctgccaatccttagtgatctcttgaatcactaaggattgacagacggg-3;
anti-Mfn1-f, 5-gatcccccggtatctctactgaagcattcaagagatgcttcagtggagatac-
gtttttggaaa-3; anti-Mfn1-r, 5-agcttttccaaaaacggtatctccactgaagc-
atctcttgaatgcttcagtagagataccgggg-3.
Antibodies—Standard Western analysis and immunofluorescence
were conducted using the following antibodies: anti-OPA1 (gift of Drs.
L. Griparic and A. van der Bliek, UCLA), anti-Mfn1 (3), anti--actin
(Sigma, clone AC-15), and anti-Myc (9E10 hybridoma).
PEG Fusion Assay—PEG fusion was performed, as described previ-
ously (3), except that cells were plated and grown in rich medium. Cell
fusion was allowed to proceed for 7 h in the presence of cycloheximide.
Pre-incubation with cycloheximide for 1–8 h did not affect the fusion
results. To evaluate outer membrane fusion in OPA1-RNAi cells, cells
expressing the mitochondrial outer membrane marker Mfn1(K88T)-
Myc (3) were used. The marker was detected by immunofluorescence
against the Myc epitope. Mfn1(K88T)-Myc is a non-functional Mfn1
that has no dominant negative effects on mitochondrial morphology.
The cells were imaged with a Plan NeoFluar 63 objective on a Zeiss
410 laser confocal microscope using AxioVision software (Carl Zeiss
MicroImaging, Inc.).
Oxygen Electrode Polarography—Oxygen consumption was meas-
ured in intact cells using a Clark oxygen electrode (Oxygraph, Hansa-
tech Instruments), as described previously (16). In brief, 2  106 cells in
500 l of TD buffer (137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4, 25 mM
Tris-HCl, pH 7.4) were added to the chamber, and mixing was
started. After 1 min of equilibration, the chamber was stoppered.
Endogenous respiration was measured as the average oxygen con-
sumption over a period of 1 min, starting 2 min after cap closure. At
4.5 min, 2,4-dinitrophenol (83 mM final concentration) was injected
into the chamber, and the maximum respiration rate was measured
for 1 min starting 0.5 min after injection. Substrate-driven respiration
rates were measured in digitonin-permeabilized cells, as described
previously (17).
RESULTS
Comparison of Mitochondrial Morphologies in Cells Lacking
Mitofusins or OPA1—Using targeted mutagenesis, we previ-
FIG. 1. Mitochondrial morphology.
A, confocal image of GFP-labeled mito-
chondria in wild-type cells. B, bar graph
showing differences in mitochondrial
morphologies in Mfn2-null, Mfn1-null,
and Mfn-dm cells. 200 cells were counted
for each genotype. C–K, mitochondrial
morphology in Mfn2-null (C–E), Mfn1-
null (F and G), Mfn-dm (H), OPA1-RNAi
(I), OPA1-RNAi cells expressing an RNAi-
resistant construct of OPA1 (J), and
OPA1-OE (K) cells. Scale bar represents
10 m.
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ously reported that Mfn1-null, Mfn2-null, and Mfn double mu-
tant (Mfn-dm) cells have fragmented mitochondria, because of
perturbations in mitochondrial fusion (3, 18). However, it re-
mains unclear to what degree these homologs are functionally
redundant and whether they cooperate to mediate normal lev-
els of mitochondrial fusion.
To address these issues, we performed a comparative anal-
ysis of mitochondrial morphology and fusion in the mutant cell
lines. Although MEFs of all three genotypes (Mfn1-null, Mfn2-
null, and Mfn-dm) showed extensive mitochondrial fragmenta-
tion, they could be readily distinguished. We found that all
mutant cells could be scored into three categories. Class I cells
showed complete fragmentation resulting in only mitochon-
drial spheres. Class II cells showed extensive fragmentation
but contained some very short mitochondrial rods (5 m in
length). Cells with any medium-length mitochondrial tubules
(5 m in length) were placed in Class III, regardless of
whether accompanying fragmentation was present. Represent-
ative images of these classes are shown in Fig. 1 for each of the
mutant MEFs. None of these three phenotypic classes ap-
proaches the tubular network typically found in wild-type cells
(Fig. 1A).
Mfn2-null cells (Fig. 1, B–E) showed all three phenotypic
classes. 20% showed no mitochondrial rods (Class I). Most
(60%) contained a few short rods in addition to mitochondrial
spheres (Class II), and 16% contained medium-length tubules
(Class III). In contrast, Mfn1-null MEFs (Fig. 1, B, F, and G)
showed more severe mitochondrial fragmentation, with 27% of
cells showing only small mitochondrial spheres (Class I). Mfn1-
null cells of Class I could be distinguished from Mfn2-null cells
of Class I by the smaller diameter of the Mfn1-null mitochon-
drial spheres. The majority (73%) of Mfn1-null cells showed a
combination of small spheres and very short rods (Class II). No
Mfn1-null cells contained Class III morphology. The presence
of more rod-shaped mitochondria in Mfn2-null cells suggests
that cells containing only Mfn1 retain more fusion activity than
cells containing only Mfn2.
Notably, all Mfn-dm cells (Fig. 1, B and H) belonged to Class
I and never showed significant mitochondrial rods or tubules.
However, in contrast to Mfn1-null or Mfn2-null cells of Class I,
Mfn-dm cells showed prominent heterogeneity in the mitochon-
drial population, characterized by a mixture of large and small
spheres. Fig. 1 summarizes the scoring of these mutant cells
and shows how even cells scored into the same class have
distinctive mitochondrial morphologies, depending on their
genotype.
We also analyzed the mitochondrial morphology of cells with
perturbed expression of OPA1, another protein implicated in
mitochondrial dynamics (4–6). OPA1-deficient cells (termed
OPA1-RNAi) were created by stably infecting wild-type MEFs
with retrovirus encoding short hairpin RNA (shRNA) directed
against OPA1. This shRNA sequence targets all isoforms of
OPA1, and indeed, OPA1-RNAi cells had 10% of wild-type
OPA1 protein levels (supplemental Fig. S1). Wild-type cells
overexpressing a Myc-tagged OPA1 were also established
(termed OPA1-OE). Similar results were obtained with un-
tagged OPA1.2
As previously described, both overexpression and underex-
pression of OPA1 lead to mitochondrial fragmentation (4–6).
However, we found that the mitochondrial morphologies of the
two types of cells could nevertheless be easily distinguished.
OPA1-OE cells (Fig. 1K) had uniform, small mitochondrial
spheres that were spread throughout the cytoplasm. In con-
trast, OPA-RNAi cells (Fig. 1I) contained mitochondria that
were highly heterogeneous in size, a phenotype similar to that
of Mfn-dm cells. Both OPA1-RNAi and Mfn-dm cells typically
had some very large mitochondrial spheres (several microns in
diameter) accompanied by a scattering of very small mitochon-
drial fragments. For both Mfn-dm (18) and OPA1-RNAi cells
(Fig. 1J), this mitochondrial fragmentation was reversible, be-
cause re-expression of the corresponding gene restored the
tubular network of mitochondria.
Requirements for OPA1 and Mitofusins in Fusion—The dif-
ferent types of mitochondrial fragmentation observed could be
explained by differences in the degree of residual mitochondrial
fusion. To test this hypothesis, we used the PEG cell fusion
technique to quantitate mitochondrial fusion in our mutant cell
lines (Table I). In each case, 250 cell hybrids were scored for
mitochondrial fusion. Consistent with previous results (18),
wild-type cells demonstrated complete fusion of all their mito-
chondria in the vast majority (97%) of cell fusion events after
7 h (Table I; Fig. 2A), whereas Mfn-dm cells showed absolutely
no fusion (Table I), even after 24 h.2
In contrast, we detected extensive, although incomplete, fu-
sion in cells containing only Mfn1 or Mfn2. Cell hybrids con-
taining only Mfn2 (Mfn1-null cells; Table I) usually showed
unambiguous and extensive partial fusion (94% of cell hybrids),
although full fusion was found in only one hybrid of 250. Most
cell hybrids containing only Mfn1 (Mfn2-null cells; Table I)
showed partial fusion (85%), but a significant fraction even
showed full fusion (14%). These residual levels of fusion activ-
ity likely explain the presence of mitochondrial rods in Mfn1-
null and Mfn2-null cells and again suggest that, in fibroblasts,
Mfn1 has a more prominent role in mitochondrial fusion than
Mfn2. Thus, the mitofusins are partially redundant in that a
single Mfn homolog is capable of mediating substantial levels of
fusion. Because mitofusins have been shown to be required on
adjacent mitochondria to mediate fusion (18), these results
indicate that homotypic Mfn interactions (Mfn1-Mfn1 and
Mfn2-Mfn2) can promote fusion.
Notably, cell hybrids between Mfn1-null and Mfn2-null cells
also had significant fusion, with 92% showing partial fusion
and 6% showing full fusion (Table I; Fig. 2B). This result
indicates, for the first time, that heterotypic Mfn interactions
(Mfn1-Mfn2) can promote fusion at endogenous expression
levels.
A previous OPA1 RNAi study shows that a reduction of
2 H. Chen and D. Chan, unpublished results.
TABLE I
PEG fusion assay
250 cell fusion events were counted for each genotypic pair. Percentages are shown in parentheses.
Cells Full fusion Partial fusion No fusion
Wild-type and wild-type 242 (97) 7 (3) 1 (0)
Mfn-dm and Mfn-dm 0 (0) 0 (0) 250 (100)
Mfn1-null and Mfn1-null 1 (0) 235 (94) 14 (6)
Mfn2-null and Mfn2-null 36 (14) 212 (85) 2 (1)
Mfn2-null and Mfn1-null 16 (6) 230 (92) 4 (2)
OPA1-RNAi and OPA1-RNAi 0 (0) 0 (0) 250 (100)
OPA1-OE and OPA1-OE 245 (98) 5 (2) 0 (0)
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OPA1 levels to 30% of wild-type results in reduction of mito-
chondrial fusion by 33% (6). Because of the inefficiency of this
RNAi experiment, it was not possible to conclude whether
OPA1 is absolutely essential for mitochondrial fusion or simply
enhances the efficiency of fusion. We addressed this issue with
our OPA1-RNAi cells, which had barely detectable levels of
OPA1 (supplemental Fig. S1). In PEG fusion assays, OPA1-
RNAi cells were devoid of any mitochondrial fusion (Table I;
Fig. 2C), even after 24 h.2 This complete fusion defect likely
explains the similar morphological defects in mitochondria in
OPA1-RNAi and Mfn-dm cells. Moreover, these results defi-
nitely demonstrated that OPA1, like mitofusins, are strictly
required for mitochondrial fusion.
Because our standard PEG fusion assay relied on mitochon-
drial matrix markers, we also used an outer mitochondrial
membrane marker to test whether outer membrane fusion is
abolished in OPA1-RNAi cells. Again, no mitochondrial fusion
was observed (Fig. 2D), indicating that both outer and inner
membrane fusion require OPA1.
In contrast, OPA1-OE cells fused their mitochondria as effi-
ciently as wild-type cells (Table I), indicating that the mito-
chondrial fragmentation observed in these cells was not due to
the lack of fusion. We also found normal levels of fusion at
earlier time points (supplemental Table S1), eliminating the
possibility that OPA1-OE cells have a subtle fusion defect. In
previous studies of mitochondrial fragmentation by OPA1 over-
expression (5, 19), it has been unclear whether fragmentation
is because of reduced fusion or increased fission. Our findings
suggest the latter possibility. Consistent with this possibility,
we found that mitochondrial fragmentation due to OPA1 over-
expression was blocked when the fission molecule Drp1 was
down-regulated by RNAi.2
Inhibition of Cell Growth—In addition to defects in mito-
chondrial morphology, we noticed that both OPA1-RNAi and
Mfn-dm cells grow significantly more slowly than wild-type
MEFs. Because cell growth is a general indicator of cell func-
tion, we quantitated this growth defect by monitoring cell pro-
liferation over the course of 4 days. Mfn2-null cells depleted of
Mfn1 by shRNA (supplemental Fig. S1) grew to only 18% of the
parental Mfn2-null control (Fig. 3A). Likewise, Mfn-dm cells
also showed very slow growth. This growth defect was revers-
ible, as demonstrated by the growth rescue of such cells upon
re-introduction of Mfn1 and Mfn2 (Fig. 3B). Interestingly, cells
lacking only Mfn2 or Mfn1 showed no growth defect,2 suggest-
ing that the residual levels of fusion documented above are
sufficient to prevent severe disruption of cell function.
Similar to Mfn-dm cells, OPA1-RNAi cells also grew much
more slowly and attained only 15% of the density of mock-
infected control cells (Fig. 3C). Finally, OPA1-OE cells, with
fusion-competent but fragmented mitochondria, grew at the
same rate as wild-type controls (Fig. 3D).
Loss of Mitochondrial —The generalized cell growth prob-
lem in cells deficient in mitochondrial fusion led us to investi-
gate what specific mitochondrial defects might exist. To moni-
tor mitochondrial , cells were stained with MitoTracker
Red, a mitochondrial dye dependent on . This staining was
compared with Su9-GFP, a marker that localizes to the mito-
chondrial matrix even in cells with low mitochondrial  (20).
For the studies described below, identical results were obtained
when a mitochondrial outer membrane marker (GFP-OMP25)
was used instead of Su9-GFP.2 Consistent with our previous
study (3), we found that both Mfn1-null and Mfn2-null cells
have mild heterogeneity in mitochondrial .2 Most Mfn1-null
cells showed some mitochondria with weak MitoTracker Red
staining, but this was restricted to only a few mitochondria
(1–10/cell). With Mfn2-null cells, only a minority of cells
showed heterogeneity in MitoTracker staining, and again this
defect was restricted to a few mitochondria.
In contrast, 100% of Mfn-dm cells showed widespread heter-
ogeneity of mitochondrial , with a large fraction of the
mitochondrial population failing to stain well with MitoTracker
Red (Fig. 4, A–C). The loss of mitochondrial  was reversible
with complete restoration of  in Mfn-null cells overexpress-
ing Mfn1.2 Depletion of OPA1 by RNAi similarly led to wide-
spread loss of mitochondrial  (Fig. 4, D–F). Cells overex-
pressing OPA1 showed no  defects (Fig. 4, G–I). Taken
together with the PEG fusion data, these results indicate that
FIG. 2. Mitochondrial fusion in mutant cells. PEG fusion of cells
containing mitochondrially targeted red fluorescent protein from Dis-
cosoma (DsRed) and GFP. Cell hybrids were formed between cells with
the following genotypes: wild-type to wild-type (A), Mfn2-null to Mfn1-
null (B), OPA1-RNAi to OPA1-RNAi (C), OPA1-RNAi (outer membrane
marker, red) to OPA1-RNAi (matrix marker, green) (D). A–D, magni-
fied view of corresponding boxed area in the left panel. Scale bars
represent 10 m.
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the severity of mitochondrial  loss correlates with the sever-
ity of fusion deficiency.
Reduced Mitochondrial Respiration—To examine the respi-
ratory capacity of mutant cells, we used oxygen electrode stud-
ies to measure the rate of oxygen consumption in intact cells.
We first measured the endogenous respiration rate and then
added a proton ionophore (2,4-dinitrophenol) to induce the
uncoupled respiration rate. Upon dissipation of the proton gra-
dient, a compensatory increase in electron transport ensued,
resulting in respiration at maximal capacity.
Wild-type MEFs had a strong endogenous respiration rate
that was capable of increasing 40–70% upon dissipation of
the proton gradient (Fig. 5A). A similar profile was observed
in OPA1-OE cells (Fig. 5B). In contrast, Mfn-dm cells had
reduced endogenous respiration, and respiration failed to
increase upon the addition of ionophore (Fig. 5C). OPA1-
RNAi cells reproducibly displayed an even more severe re-
duction in endogenous respiration and again no increase
upon the addition of ionophore (Fig. 5E). The more severe
defect found in OPA1-RNAi cells, as compared with that of
Mfn-dm cells, was highly reproducible between multiple tri-
als (Fig. 5G).
To further dissect the respiration defect in our fusion-defi-
cient cell lines, we measured substrate-driven respiration in
permeabilized cells. Specifically, we used glutamate and
malate to measure complex I activity, succinate/glycerol-3-
FIG. 3. Growth defects in Mfn-dm
and OPA1-RNAi cells. A, Mfn2-null
cells, uninfected or infected with Mfn1-
shRNA. Mfn1-shRNA was used so that a
direct comparison to its parental Mfn2-
null cell line could be made. Similar
growth defects are seen in Mfn-dm cells.
B, Mfn-dm cells, uninfected or overex-
pressing Mfn1 and Mfn2. C, wild-type
cells, mock-infected or infected with
OPA1-shRNA. D, wild-type cells, mock-
infected or overexpressing OPA1. Cells
were counted in triplicate, and the mean
number of control cells on day 4 was set to
100%. Error bars represent standard
deviation.
FIG. 4.  loss in mutant cells. Mi-
tochondrial  was examined by Mito-
Tracker Red staining (left panels) and
compared with Su9-GFP (middle panels)
in the merged images (right panels). A–C,
Mfn-dm. D–F, OPA1-RNAi. G–I, OPA1-
OE. Scale bar represents 10 m.
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phosphate for complex III, and N,N,N,N-tetramethyl-p-phe-
nylenediamine/ascorbate for complex IV. Respiratory capacity
was attenuated for all three complexes in the mutant lines
(Fig. 6).
An important aspect of the respiration defects was that they
were reversible. Mfn-dm cells had a restored respiration profile
upon expression of exogenous Mfn1 and Mfn2 (Fig. 5, D and G).
Even more strikingly, expression of OPA1 in OPA1-RNAi cells
completely restored normal respiration (Fig. 5, F and G), de-
spite the severe defect in OPA1-RNAi cells. This reversibility
indicates that, unlike in yeast, respiration defects in mamma-
lian cells are not secondary to a complete loss of mtDNA, and
suggests that lack of fusion itself affects respiration. It is in-
teresting to note that cells lacking only Mfn1 or Mfn2 had no
gross defect in cell growth or bulk respiration,2 implying that
low levels of mitochondrial fusion are sufficient to prevent at
least some of the functional defects shown here.
DISCUSSION
Requirement of Mfns and OPA1 in Mitochondrial Membrane
Fusion—There is some evidence that Mfn1 and Mfn2 may have
distinct activities (6, 21), but they nevertheless have similar
roles in mitochondrial membrane fusion. Because these two
mitofusin homologs have overlapping expression patterns, it is
important to clarify whether they play redundant roles in tis-
sues where they are co-expressed and whether they can coop-
erate to mediate mitochondrial fusion. Our study showed that
both Mfn1 and Mfn2 play a major role in maintaining normal
levels of mitochondrial fusion. In the absence of either homolog,
mitochondrial fragmentation results from a drastic reduction
FIG. 5. Reversible respiratory de-
fects in mutant cells. Representative
respiration profiles are shown for the fol-
lowing cells: wild-type cells (A), OPA1-OE
cells (B), Mfn-dm cells (C), Mfn-dm cells
expressing Mfn1 and Mfn2 (D), OPA1-
RNAi cells (E), and OPA1-RNAi cells ex-
pressing an RNAi-resistant construct of
OPA1 (F). Arrows denote when the cell
chamber was closed (left) and when 2,4-
dinitrophenol was added to obtain the
maximum respiration rate (right). Rates
of oxygen depletion (nmol/ml/min) are
shown above their respective time inter-
vals. G, bar graph showing reversible res-
piratory defects in OPA1-RNAi and
Mfn-dm cells. Error bars represent stand-
ard deviation.
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in the extent of mitochondrial fusion, as observed by the PEG
fusion assay. Nevertheless, a single mitofusin is sufficient to
generate residual mitochondrial fusion that can be readily de-
tected. In mouse fibroblasts, Mfn1 appears to play a more
prominent role than Mfn2, as evidenced by the greater loss of
mitochondrial fusion and more severe fragmentation found in
Mfn1-null MEFs.
Recent evidence suggests that mitofusins act in trans to
mediate mitochondrial tethering and fusion (18). Our PEG
fusion assays, using various combinations of Mfn1-null and
Mfn2-null cells, further suggest that mitochondrial fusion,
in vivo, can be mediated by three distinct complexes acting in
trans: Mfn1 homotypic complexes, Mfn2 homotypic complexes,
and Mfn1/Mfn2 heterotypic complexes.
Our results clarify the puzzling observation reported here
and by others (4–6, 19) that overexpression as well as deple-
tion of OPA1 causes mitochondrial fragmentation. We find that
OPA1 deficiency abolishes all mitochondrial fusion. In con-
trast, fragmentation due to overexpression of OPA1 does not
result from a fusion defect but is Drp1-dependent. The basis for
this fragmentation remains to be resolved. One possibility is
that overexpression of OPA1 can lead to an imbalance in OPA1
isoforms. A similar phenomenon is observed in yeast. Pcp1p is
the rhomboid protease responsible for cleavage of Mgm1p (23,
24). The proper balance of long and short isoforms of Mgm1p is
critical for maintenance of tubular mitochondrial morphology
(25, 26). Yeast lacking Pcp1p produce only the long form of
Mgm1p and have fragmented mitochondria that are fusion-
competent (25).
Additional Functions of Mitochondrial Fusion—Previous
studies have clearly substantiated the role of mitochondrial
fusion and fission in maintenance of mitochondrial morphology
(3, 12, 13). It is likely that, depending on the cell type, the
shape of mitochondria can directly influence their functional
properties. For example, it has been hypothesized that the
filamentous and interconnected structure of mitochondria in
some cells may facilitate the delivery of energy or membrane
potential to specific regions of the cell (27).
In addition to this role in regulation of organelle shape, our
studies suggest that mitochondrial fusion per se is important
for mitochondrial function. Mfn1-null and Mfn2-null MEFs
contain highly fragmented mitochondria but retain enough
residual mitochondrial fusion to escape major cellular dysfunc-
tion. In contrast, Mfn-dm cells and OPA1-RNAi cells lack any
detectable mitochondrial fusion. These cells grow poorly, show
widespread heterogeneity in mitochondrial , and suffer re-
duced respiratory capacity. In polarography measurements,
these fusion-incompetent cells respire at maximal rates in the
absence of an uncoupler, and these rates are severely depressed
compared with wild-type cells. Because these cells have in-
creased heterogeneity in their mitochondria, this phenomenon
may reflect a compensatory mechanism for the reduced number
of functional mitochondria. Furthermore, the mutant cells have
little or no reserve capacity for increased respiration.
These functional deficits do not appear to be secondary to
mitochondrial fragmentation, because OPA1-overexpressing
cells have severely fragmented mitochondria without loss of
mitochondrial fusion and do not suffer cellular defects. Also of
note is that the cell growth and respiratory defects are not due to
an irreversible loss of mtDNA as seen in yeast, because re-
introduction of the relevant protein restores normal cell function.
It remains a formal possibility that the severe functional
defects observed in Mfn-dm and OPA1-RNAi cells may be due
to as yet unknown functions of Mfns or OPA1, apart from
fusion. This issue is more of a concern with OPA1, because this
protein is still poorly understood and has been proposed to play
a role in inner membrane remodeling (4). Such additional func-
tions may explain why the respiration defect in OPA1-RNAi
cells is significantly more severe than in Mfn-dm cells. How-
ever, we favor the explanation that the functional defects ob-
served in Mfn-dm and OPA1-RNAi cells are specifically be-
cause of the lack of mitochondrial fusion. Mitofusins are
becoming increasingly well understood and appear to play a
direct role in mediating mitochondrial membrane fusion (18).
In addition, the functional deficits in Mfn-dm and OPA1-RNAi
cells are very similar, consistent with the hypothesis that they
arise from a common defect.
A major challenge for future studies will be to identify the
pathway through which loss of fusion in mammalian cells re-
sults in mitochondrial dysfunction. In some experimental sys-
tems, mitochondrial fusion has been associated with protective
effects on mitochondrial function. Cell hybrids between paren-
tal cells containing mutant mtDNA molecules result in resto-
ration of respiratory activity (28), indicating that complemen-
tation of mtDNA products can occur in fused mitochondria.
Moreover, mice containing pathogenic mtDNA mutations are
protected frommitochondrial dysfunction until a critical load of
mutant mtDNA molecules is reached (22). These results again
suggest that mitochondrial fusion can allow interaction of
mtDNA gene products and enable protection of mitochondrial
function.
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